Nature's Sunshine Products (NATR) Competitors

$22.22 -0.06 (-0.27%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$21.82 -0.40 (-1.82%)

As of 05/15/2026 05:21 PM Eastern

NATR vs. HLF, USNA, NUS, MED, and VERU

Should you buy Nature's Sunshine Products stock or one of its competitors? MarketBeat compares Nature's Sunshine Products with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nature's Sunshine Products include Herbalife (HLF), USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Medifast (MED), and Veru (VERU). These companies are all part of the "personal products" industry.

How does Nature's Sunshine Products compare to Herbalife?

Nature's Sunshine Products (NASDAQ:NATR) and Herbalife (NYSE:HLF) are both small-cap personal products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

Herbalife has a net margin of 4.67% compared to Nature's Sunshine Products' net margin of 4.06%. Nature's Sunshine Products' return on equity of 14.67% beat Herbalife's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nature's Sunshine Products	4.06%	14.67%	9.27%
Herbalife	4.67%	-41.47%	8.24%

79.4% of Nature's Sunshine Products shares are held by institutional investors. 3.1% of Nature's Sunshine Products shares are held by insiders. Comparatively, 5.1% of Herbalife shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Nature's Sunshine Products has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market. Comparatively, Herbalife has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market.

Herbalife has higher revenue and earnings than Nature's Sunshine Products. Herbalife is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20
Herbalife	$5.04B	0.26	$228.30M	$2.28	5.62

In the previous week, Herbalife had 4 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 11 mentions for Herbalife and 7 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.19 beat Herbalife's score of 0.48 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Herbalife	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nature's Sunshine Products currently has a consensus price target of $35.00, indicating a potential upside of 57.52%. Herbalife has a consensus price target of $17.80, indicating a potential upside of 38.92%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, analysts plainly believe Nature's Sunshine Products is more favorable than Herbalife.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Herbalife	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Nature's Sunshine Products beats Herbalife on 8 of the 15 factors compared between the two stocks.

How does Nature's Sunshine Products compare to USANA Health Sciences?

USANA Health Sciences (NYSE:USNA) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Nature's Sunshine Products has a consensus target price of $35.00, indicating a potential upside of 57.52%. Given Nature's Sunshine Products' stronger consensus rating and higher probable upside, analysts plainly believe Nature's Sunshine Products is more favorable than USANA Health Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

USANA Health Sciences has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market.

Nature's Sunshine Products has a net margin of 4.06% compared to USANA Health Sciences' net margin of 0.96%. Nature's Sunshine Products' return on equity of 14.67% beat USANA Health Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	0.96%	6.21%	4.50%
Nature's Sunshine Products	4.06%	14.67%	9.27%

In the previous week, Nature's Sunshine Products had 6 more articles in the media than USANA Health Sciences. MarketBeat recorded 7 mentions for Nature's Sunshine Products and 1 mentions for USANA Health Sciences. Nature's Sunshine Products' average media sentiment score of 1.19 beat USANA Health Sciences' score of 0.50 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
USANA Health Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nature's Sunshine Products has lower revenue, but higher earnings than USANA Health Sciences. Nature's Sunshine Products is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
USANA Health Sciences	$925.26M	0.36	$10.76M	$0.47	38.30
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20

54.3% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 0.8% of USANA Health Sciences shares are owned by company insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Nature's Sunshine Products beats USANA Health Sciences on 14 of the 16 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Nu Skin Enterprises?

Nu Skin Enterprises (NYSE:NUS) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap personal products companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Nu Skin Enterprises has higher revenue and earnings than Nature's Sunshine Products. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nu Skin Enterprises	$1.49B	0.20	$160.20M	$1.10	5.58
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20

82.8% of Nu Skin Enterprises shares are held by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are held by institutional investors. 2.8% of Nu Skin Enterprises shares are held by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Nature's Sunshine Products has a net margin of 4.06% compared to Nu Skin Enterprises' net margin of 3.78%. Nature's Sunshine Products' return on equity of 14.67% beat Nu Skin Enterprises' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nu Skin Enterprises	3.78%	7.47%	4.21%
Nature's Sunshine Products	4.06%	14.67%	9.27%

Nu Skin Enterprises has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.95, suggesting that its share price is 5% less volatile than the broader market.

In the previous week, Nature's Sunshine Products had 3 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 7 mentions for Nature's Sunshine Products and 4 mentions for Nu Skin Enterprises. Nature's Sunshine Products' average media sentiment score of 1.19 beat Nu Skin Enterprises' score of 0.29 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nu Skin Enterprises	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Nu Skin Enterprises pays an annual dividend of $0.24 per share and has a dividend yield of 3.9%. Nature's Sunshine Products pays an annual dividend of $0.40 per share and has a dividend yield of 1.8%. Nu Skin Enterprises pays out 21.8% of its earnings in the form of a dividend. Nature's Sunshine Products pays out 36.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Nu Skin Enterprises is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Nature's Sunshine Products beats Nu Skin Enterprises on 11 of the 17 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Medifast?

Nature's Sunshine Products (NASDAQ:NATR) and Medifast (NYSE:MED) are both small-cap personal products companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

Nature's Sunshine Products has a beta of 0.95, indicating that its stock price is 5% less volatile than the broader market. Comparatively, Medifast has a beta of 0.55, indicating that its stock price is 45% less volatile than the broader market.

In the previous week, Nature's Sunshine Products and Nature's Sunshine Products both had 7 articles in the media. Nature's Sunshine Products' average media sentiment score of 1.19 beat Medifast's score of 0.74 indicating that Nature's Sunshine Products is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medifast	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Nature's Sunshine Products presently has a consensus target price of $35.00, suggesting a potential upside of 57.52%. Medifast has a consensus target price of $12.00, suggesting a potential downside of 4.34%. Given Nature's Sunshine Products' stronger consensus rating and higher possible upside, equities research analysts plainly believe Nature's Sunshine Products is more favorable than Medifast.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Medifast	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Nature's Sunshine Products has higher revenue and earnings than Medifast. Medifast is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20
Medifast	$385.79M	0.36	-$18.67M	-$1.83	N/A

Nature's Sunshine Products has a net margin of 4.06% compared to Medifast's net margin of -5.78%. Nature's Sunshine Products' return on equity of 14.67% beat Medifast's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nature's Sunshine Products	4.06%	14.67%	9.27%
Medifast	-5.78%	-4.80%	-3.83%

79.4% of Nature's Sunshine Products shares are owned by institutional investors. Comparatively, 95.5% of Medifast shares are owned by institutional investors. 3.1% of Nature's Sunshine Products shares are owned by insiders. Comparatively, 3.7% of Medifast shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Nature's Sunshine Products beats Medifast on 13 of the 15 factors compared between the two stocks.

How does Nature's Sunshine Products compare to Veru?

Veru (NASDAQ:VERU) and Nature's Sunshine Products (NASDAQ:NATR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership.

Veru has a beta of -1.19, meaning that its share price is 219% less volatile than the broader market. Comparatively, Nature's Sunshine Products has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veru	$16.89M	2.01	-$22.73M	-$1.26	N/A
Nature's Sunshine Products	$489.79M	0.80	$19.52M	$1.10	20.20

Veru presently has a consensus price target of $23.00, suggesting a potential upside of 990.05%. Nature's Sunshine Products has a consensus price target of $35.00, suggesting a potential upside of 57.52%. Given Veru's higher possible upside, analysts plainly believe Veru is more favorable than Nature's Sunshine Products.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veru	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Nature's Sunshine Products	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

47.2% of Veru shares are owned by institutional investors. Comparatively, 79.4% of Nature's Sunshine Products shares are owned by institutional investors. 14.2% of Veru shares are owned by insiders. Comparatively, 3.1% of Nature's Sunshine Products shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Nature's Sunshine Products has a net margin of 4.06% compared to Veru's net margin of 0.00%. Nature's Sunshine Products' return on equity of 14.67% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veru	N/A	-54.72%	-39.09%
Nature's Sunshine Products	4.06%	14.67%	9.27%

In the previous week, Veru had 5 more articles in the media than Nature's Sunshine Products. MarketBeat recorded 12 mentions for Veru and 7 mentions for Nature's Sunshine Products. Nature's Sunshine Products' average media sentiment score of 1.19 beat Veru's score of 0.75 indicating that Nature's Sunshine Products is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veru	1 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Nature's Sunshine Products	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Nature's Sunshine Products beats Veru on 11 of the 15 factors compared between the two stocks.

Get Nature's Sunshine Products News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NATR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NATR vs. The Competition

Export

Metric	Nature's Sunshine Products	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$390.74M	$3.00B	$6.38B	$12.30B
Dividend Yield	N/A	1.97%	2.81%	5.26%
P/E Ratio	20.20	17.57	20.66	25.27
Price / Sales	0.80	267.37	555.40	72.94
Price / Cash	10.22	57.31	42.43	54.86
Price / Book	2.34	4.33	9.87	6.90
Net Income	$19.52M	$72.19M	$3.57B	$334.66M
7 Day Performance	-8.30%	-3.06%	0.23%	0.12%
1 Month Performance	-18.73%	-5.08%	-2.54%	-0.18%
1 Year Performance	49.43%	36.79%	33.54%	30.62%

Nature's Sunshine Products Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NATR Nature's Sunshine Products	4.175 of 5 stars	$22.22 -0.3%	$35.00 +57.5%	+49.4%	$390.74M	$489.79M	20.20	850	Positive News
HLF Herbalife	4.5783 of 5 stars	$13.62 +0.8%	$17.80 +30.7%	+81.9%	$1.40B	$5.04B	5.98	8,500	Insider Trade
USNA USANA Health Sciences	2.5095 of 5 stars	$17.40 -0.2%	N/A	-40.5%	$321.70M	$925.26M	37.02	1,570
NUS Nu Skin Enterprises	3.0365 of 5 stars	$6.56 -1.0%	N/A	-19.2%	$319.08M	$1.49B	5.96	2,800
MED Medifast	1.7273 of 5 stars	$12.56 +1.3%	$12.00 -4.4%	-10.4%	$137.88M	$385.79M	N/A	870

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NATR) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nature's Sunshine Products (NATR) Competitors

NATR vs. HLF, USNA, NUS, MED, and VERU

How does Nature's Sunshine Products compare to Herbalife?

Summary

How does Nature's Sunshine Products compare to USANA Health Sciences?

Summary

How does Nature's Sunshine Products compare to Nu Skin Enterprises?

Summary

How does Nature's Sunshine Products compare to Medifast?

Summary

How does Nature's Sunshine Products compare to Veru?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NATR vs. The Competition

Nature's Sunshine Products Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nature's Sunshine Products (NATR) Competitors

NATR vs. HLF, USNA, NUS, MED, and VERU

How does Nature's Sunshine Products compare to Herbalife?

Is NATR or HLF more profitable?

Do institutionals and insiders have more ownership in NATR or HLF?

Which has more volatility & risk, NATR or HLF?

Which has better earnings & valuation, NATR or HLF?

Does the media refer more to NATR or HLF?

Do analysts prefer NATR or HLF?

Summary

How does Nature's Sunshine Products compare to USANA Health Sciences?

Do analysts rate USNA or NATR?

Which has more volatility & risk, USNA or NATR?

Is USNA or NATR more profitable?

Does the media favor USNA or NATR?

Which has stronger valuation and earnings, USNA or NATR?

Do institutionals & insiders have more ownership in USNA or NATR?

Summary

How does Nature's Sunshine Products compare to Nu Skin Enterprises?

Which has preferable earnings & valuation, NUS or NATR?

Do insiders & institutionals believe in NUS or NATR?

Is NUS or NATR more profitable?

Which has more risk & volatility, NUS or NATR?

Does the media favor NUS or NATR?

Do analysts rate NUS or NATR?

Is NUS or NATR a better dividend stock?

Summary

How does Nature's Sunshine Products compare to Medifast?

Which has more volatility & risk, NATR or MED?

Does the media favor NATR or MED?

Do analysts rate NATR or MED?

Which has preferable earnings and valuation, NATR or MED?

Is NATR or MED more profitable?

Do institutionals and insiders hold more shares of NATR or MED?

Summary

How does Nature's Sunshine Products compare to Veru?

Which has more volatility and risk, VERU or NATR?

Which has stronger earnings and valuation, VERU or NATR?

Do analysts rate VERU or NATR?

Do institutionals & insiders hold more shares of VERU or NATR?

Is VERU or NATR more profitable?

Does the media prefer VERU or NATR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NATR vs. The Competition

Nature's Sunshine Products Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools